欧普康视 (300595)
AUTEK CHINA INC
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 89528.91
- Circulating A-Shares(W): 66849.48
- Earnings Per Share(RMB): 0.4950
- Net Assets Per Share(RMB): 5.5152
- Operating Revenue(W RMB): 143279.13
- Total Profit(W RMB): 57955.00
- Net Profit Attributable to Parent(W RMB): 44204.96
- Net Profit Growth Rate(%): -15.41
- Weighted Return on Equity(%): 9.1300
- Operating Cash Flow Per Share(RMB): 0.6410
- Undistributed Profit Per Share(RMB): 2.9180
- Capital Reserve Per Share(RMB): 1.2508
2. Main Business
The main business covers:
- Vision care products
- Vision care services
3. Company Basic Information
- Company Name: OVCTEK China Inc.
- Listing Date: 2017-01-17
- Industry: Medicine & Healthcare - Medical Devices (CSRC Industry: Special Equipment Manufacturing)
- Address: No. 4899, Wangjiang West Road, High-tech Zone, Hefei City, Anhui Province
- Website: www.orthok.cn
- Company Profile: The company's predecessor was OVCTEK Technology (Hefei) Co., Ltd., a wholly foreign-owned enterprise established in September 2000. In November 2013, the company was restructured into a joint-stock company. The company is primarily engaged in vision care products and services.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Nanjing Outao Information Technology Co., Ltd. | General Legal Person | 10046.44 | 15.03 |
| 2 | Hefei Oupu Minsheng Investment Management Partnership (Limited Partnership) | General Legal Person | 2905.62 | 4.35 |
| 3 | ChinaAMC CSI Medical Care ETF | Fund | 1524.10 | 2.28 |
| 4 | E Fund ChiNext ETF | Fund | 1090.64 | 1.63 |
| 5 | CSI 500 ETF | Fund | 780.83 | 1.17 |
| 6 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 655.00 | 0.98 |
| 7 | Penghua Pharmaceutical Technology Stock Fund Class A | Fund | 389.76 | 0.58 |
5. Concept Sectors
- Gene Concept
- Cross-border E-commerce
- Internet Celebrity Economy
- AI Glasses
- Margin Trading & Securities Lending
- ChiNext 300
- ChiNext Quality
- ChiNext Medicine
- ChiNext 200
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
